The coming age of data-driven medicine: Translational bioinformatics' next frontier

Journal of the American Medical Informatics Association

Volumn 19, Issue E1, 2012, Pages

  Shah, Nigam H ^a   Tenenbaum, Jessica D ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CLINICAL PRACTICE; DISEASE ASSOCIATION; EDITORIAL; ELECTRONIC MEDICAL RECORD; GENETIC ASSOCIATION; GENOME; GENOTYPE; HUMAN; MEDICAL INFORMATION; PHENOTYPE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPUTATIONAL BIOLOGY; DATA MINING; MEDICAL INFORMATICS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84863553057     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2012-000969     Document Type: Editorial

References (49)

1. Butte AJ, Shah NH. Computationally translating molecular discoveries into tools for medicine: translational bioinformatics articles now featured in JAMIA. J Am Med Inform Assoc 2011;18:352-3.
2. Trelles O, Prins P, Snir M, et al. Big data, but are we ready? Nat Rev Genet 2011;12:224.
3. Schadt EE, Linderman MD, Sorenson J, et al. Cloud and heterogeneous computing solutions exist today for the emerging big data problems in biology. Nat Rev Genet 2011;12:224.
4. Green ED, Guyer MS; National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011;470:204-13.
5. Berg JM. National centers for biomedical computing: from the BISTI report to the future. J Am Med Inform Assoc 2012;19:151-2.
6. Ohno-Machado L. Informatics research to enable clinically relevant, personalized genomic medicine. J Am Med Inform Assoc 2012;19:149-50.
7. Floratos A, Honig B, Pe'er D, et al. Using systems and structure biology tools to dissect cellular phenotypes. J Am Med Inform Assoc 2012;19:171-5.
8. Musen MA, Noy NF, Shah NH, et al. The National Center for Biomedical Ontology. J Am Med Inform Assoc 2012;19:190-5.
9. Kohane IS, Churchill SE, Murphy SN. A translational engine at the national scale: informatics for integrating biology and the bedside. J Am Med Inform Assoc 2012;19:181-5.
10. Liu M, Wu Y, Chen Y, et al. Large-scale prediction of adverse drug reactions by integrating chemical, biological, and phenotypic properties of drugs. J Am Med Inform Assoc 2012;19:e28-35.
11. Bhavnani SK, Bellala G, Victor S, et al. The Role of Complementary Bipartite Visual Analytical Representations in the Analysis of SNPs: A Case Study in Ancestral Informative Markers. J Am Med Inform Assoc 2012;19:e5-12.
12. Russu A, Malovini A, Puca AA, et al. Stochastic model search with binary outcomes for Genome-Wide Association Studies. J Am Med Inform Assoc 2012;19:e13-20.
13. Morgan AA, Chen R, Butte AJ, et al. Clinical utility of sequence-based genotype compared with that derivable from genotyping arrays. J Am Med Inform Assoc 2012;19:e21-7.
14. Kho AN, Hayes MG, Rasmussen-Torvik L, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc 2012;19:212-18.
15. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011;13:255-62.
16. Mayer AN, Dimmock DP, Arca MJ, et al. A timely arrival for genomic medicine. Genet Med 2011;13:195-6.
17. Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet 2010;375:1525-35.
18. Samani NJ, Tomaszewski M, Schunkert H. The personal genomedthe future of personalised medicine? Lancet 2010;375:1497-8.
19. Harpaz R, et al. Novel data mining methodologies for adverse drug event discovery and analysis. Nature Clinical Pharmacology and Therapeutics. In press (accepted 5 Mar 2012).
20. Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf 2009;18:427-36.
21. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 2002;25:381-92.
22. Weiss-Smith S, Deshpande G, Chung S, et al. The FDA drug safety surveillance program: adverse event reporting trends. Arch Intern Med 2011;171:591-3.
23. Norén N, Sundberg R, Bate A, et al. A statistical methodology for drug-drug interaction surveillance. Stat Med 2008;27:3057-70.
24. Tatonetti NP, Denny JC, Murphy SN, et al. Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. Clin Pharmacol Ther 2011;90:133-42.
25. Tatonetti NP, Ye PP, Daneshjou R, et al. Data-driven prediction of drug effects and interactions. Sci Transl Med 2012;4:125-31.
26. Cami A, Arnold A, Manzi S, et al. Predicting adverse drug events using pharmacological network models. Sci Transl Med 2011;3:114-27.
27. Pouliot Y, Chiang AP, Butte AJ. Predicting adverse drug reactions using publicly available PubChem BioAssay data. Clin Pharmacol Ther 2011;90:90-9.
28. Vilar S, Harpaz R, Chase HS, et al. Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis. J Am Med Inform Assoc 2011;18(Suppl 1):i73-80.
29. Liu Y, LePendu P, Iyer S, et al. Using temporal patterns in medical records to discern adverse drug events from indications. AMIA Summit on Clinical Research Informatics. San Francisco: AMIA, 2012.
30. LePendu P, Iyer SV, Fairon C, et al. Annotation analysis for testing drug safety signals. Journal of Biomedical Semantics 2012;3(Suppl 1):S5.
31. Brownstein JS, Sordo M, Kohane IS, et al. The telltale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS One 2007;2:e840.
32. Harpaz R, Chase H, Friedman C. Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinformatics 2010;11 (Suppl 9):S7.
33. Dore D, Seeger J, Arnold Chan K. Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr Med Res Opin 2009;25:1019-27.
34. Nadkarni P. Drug safety surveillance using de-identified EMR and claims data: issues and challenges. J Am Med Inform Assoc 2010;17:671-4.
35. Brown JS, Kulldorff M, Chan KA, et al. Early detection of adverse drug events within populationbased health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 2007;16:1275-84.
36. Shetty KD, Dalal S. Using information mining of the medical literature to improve drug safety. J Am Med Inform Assoc 2011;18:668-74.
37. Chee BW, Berlin R, Schatz B. Predicting adverse drug events from personal health messages. AMIA Annu Symp Proc 2011;2011:217-26.
38. Sobek M, Cleveland L, Flood S, et al. Big data: large-scale historical infrastructure from the Minnesota Population Center. Hist Methods 2011;44:61-8.
39. Fox B. Using big data for big impact. How predictive modeling can affect patient outcomes. Health Manag Technol 2012;33:32.
40. Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012;148: 1293-307.
41. Frankovich J, Longhurst CA, Sutherland SM. Evidence-based medicine in the EMR era. N Engl J Med 2011;365:1758-9.
42. Halevy A, Norvig P, Pereira F. The unreasonable effectiveness of data. IEEE Intelligent Systems 2009;24:8-12.
43. Hays J, Efros AA. Scene completion using millions of photographs. Commun ACM 2008;51:87-94.
44. Bringardner J. Winning the lawsuit: data miners dig for dirt. Wired Magazine 2008:16-07.
45. Michel J-B, Shen YK, Aiden AP, et al. Quantitative analysis of culture using millions of digitized books. Science 2011;331:176-82.
46. CBO. The Long Term Outlook for Health Care Spending. 2007. http://www.cbo.gov/sites/default/files/cbofiles/ftpdocs/87xx/doc8758/11-13-lt-health.pdf
47. Lorenzi NM. AMIA's Realigned Strategic Plan. 2011. http://www.amia.org/issues/amias-realignedstrategic-plan (accessed 13 Mar 2012).
48. Friedman CP, Wong AK, Blumenthal D. Achieving a nationwide learning health system. Sci Transl Med 2010;2:57cm29.
49. LePendu P, Musen MA, Shah NH. The age of datadriven medicine: mining the electronic health record. International Conference on Biomedical Ontologies. Buffalo, NY: CEUR, 2011:435.